LOPINAVIR

作品数:15被引量:23H指数:2
导出分析报告
相关领域:医药卫生更多>>
相关作者:卢洪洲姚亚敏张丽军孙骥沐俊更多>>
相关机构:复旦大学苏州大学华东师范大学北京协和医院更多>>
相关期刊:《Journal of Pharmaceutical Analysis》《Asian Pacific Journal of Tropical Medicine》《Computational Chemistry》《Proceedings of Anticancer Research》更多>>
相关基金:国家自然科学基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Influence of traditional Chinese medicines on the in vivo metabolism of lopinavir/ritonavir based on UHPLC-MS/MS analysis被引量:1
《Journal of Pharmaceutical Analysis》2022年第2期270-277,共8页Linlin Li Xinxiang Yu Dongmin Xie Ningning Peng Weilin Wang Decai Wang Binglong Li 
supported by the Development Plan of Science and Technology of Traditional Chinese Medicine in Shandong Province(Grant No.:2019e0350);the Development Plan of Medical and Health Technology in Shandong Province(Grant No.:2018WS133).
A fast,reliable,and cost-effective liquid chromatography-tandem mass spectrometry method was established to determine the effects of the traditional Chinese medicine employed to treat coronavirus disease 2019,namely,L...
关键词:Lopinavir/ritonavir Combination of Chinese and western medicine Drug-drug interaction Ultra high-performance liquid chromatography-tandem mass SPECTROMETRY PHARMACOKINETICS COVID-19 
Lopinavir/Ritonavir in the Treatment of COVID-19:A Systematic Review and Meta-Analysis
《Proceedings of Anticancer Research》2021年第5期19-25,共7页Yan Du Tongtong Wang Bo Li Fang Pang Xuanguo Zhang Li Xi 
Objective:To systematically evaluate the efficacy and safety of lopinavir/ritonavir(LPV/r)in the treatment of COVID-19.Methods:PubMed,Embase,Ovid,CNKI,CBM,Wanfang,and VIP databases were searched to obtain the clinical...
关键词:Lopinavir/ritonavir COVID-19 SARS-CoV-2 Systematic review META-ANALYSIS 
Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats
《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》2021年第7期599-602,共4页Yunzhen HU Minjuan ZUO Xiaojuan WANG Rongrong WANG Lu LI Xiaoyang LU Saiping JIANG 
the National Natural Science Foundation of China(No.81703612)。
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-Co V-2) has occasioned worldwide alarm. Globally, the number of reported confirmed cases has exceeded 84...
关键词:DRUGS ACUTE RESPIRATORY 
<i>In Situ</i>Characterization of Lopinavir by ATR-FTIR Biospectroscopy
《Computational Chemistry》2020年第3期27-42,共16页Alireza Heidari 

Lopinavir is an antiretroviral of the protease inhibitor class (Figure 1 and Figure 2). It is used against HIV infections as a fixed-dose combi...

关键词:ATR-FTIR Biospectroscopy Simulation LOPINAVIR Breakdown Coronavirus Disease-2019 COVID-19 Infection Protective and Therapeutic Effect Potent Drug 
基于洛匹那韦(Lopinavir)合成的高考模拟试题的命制
《数理化学习(高中版)》2020年第6期63-64,共2页袁欢 姜建文 
江西省教师质量监测评估与服务协同创新中心项目资助(JXJSZLB03)
结合近几年全国Ⅰ卷有机选做题的考查形式和特点,以抗新型冠状病毒肺炎的药物——洛匹那韦的合成路线为知识载体,设计一道2020有机合成模拟试题.
关键词:有机合成 模拟试题 洛匹那韦 
Comparative effectiveness and safety of ribavirin plus interferon-alpha,lopinavir/ritonavir plus interferon-alpha,and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019:study protocol被引量:2
《Chinese Medical Journal》2020年第9期1132-1134,共3页Yan-Ming Zeng Xiao-Lei Xu Xiao-Qing He Sheng-Quan Tang Yao Li Yin-Qiu Huang Vijay Harypursat Yao-Kai Chen 
This work was supported by the Chongqing Special Research Project for Prevention and Control of Novel Coronavirus Pneumonia(No.cstc2020jscx-fyzx0074)。
To the Editor:At the end of 2019,an outbreak of novel coronavirus disease 2019(COVID-19),caused by 2019-nCov,causing widespread novel coronavirus disease.This outbreak of COVID-19 occurred during the period of the 202...
关键词:PATIENTS RIBAVIRIN INTERFERON 
Dose prediction of lopinavir/ritonavir for 2019-novel coronavirus (2019-nCoV) infection based on mathematic modeling
《Asian Pacific Journal of Tropical Medicine》2020年第3期137-138,共2页Sora Yasri Viroj Wiwanitkit 
Wuhan novel coronavirus or 2019-novel coronavirus(2019-nCoV)infection is a rapidly emerging respiratory viral disease[1].2019-nCoV infection is characterized as febrile illness with possible severe lung complication[1...
关键词:DOSE PREDICTION of lopinavir/ritonavir for 2019-novel CORONAVIRUS INFECTION based on mathematic MODELING 
Synthesis of a New Lopinavir Phosphinic Analog as HIV-1 Inhibitor
《Journal of Materials Science and Chemical Engineering》2019年第7期36-41,共6页Ruba Kellow Magdalini Matziari 
HIV/AIDS has been one of the most devastating global diseases. HIV-1 protease proteolytic action is responsible for the manufacture of grown, infectious species, consequently HIV-1 protease has become an attractive go...
关键词:HIV-1 LOPINAVIR PL1 
Effect of ABCB1 C3435T Polymorphism on Clinical Outcomes in Kenyan HIV Patients on Lopinavir-Based Regimens
《Journal of Pharmacy and Pharmacology》2017年第7期478-488,共11页Kagia Richard Okalebo Faith Oluka Margaret Njoroge Anne Bulimo Wallace 
ATP Binding Cassette sub-family B member 1 (ABCB1) affects disposition of many drugs and thus affects the pharmacokinetics of drugs and ultimately treatment response. Polymorphisms of ABCB 1 especially ABCB 1 C3435T...
关键词:ABCB 1 C3435T polymorphism lopinavir-based regimens creatinine levels CD4 cell counts ALT. 
Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients被引量:10
《Chinese Medical Journal》2014年第14期2632-2636,共5页Cai Juan Xiao Jiang Zhang Qiang 
Background In the era of highly active antiretroviral therapy (HAART), the use of antiretrovirals as post-exposure prophylaxis (PEP) was the most important strategy for preventing occupational exposure to blood or...
关键词:post-exposure prophylaxis HIV/AIDS highly active antiretroviral therapy side effect 
检索报告 对象比较 聚类工具 使用帮助 返回顶部